Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care

初级保健中长期幸存者的扩展癌症教育 (EXCELS)

基本信息

项目摘要

There are 13.7 million cancer survivors in the United States. By 2050 the rate of growth for cancer survivors is expected to outpace the rate of growth for incident cancer cases. Approximately 70 percent of cancer survivors have co-morbid conditions that require a comprehensive approach to their medical care. Yet, cancer survivors do not receive recommended follow-up care at appropriate levels, with regard to both needed preventive care and chronic disease management. Survivors may benefit from psychosocial tools and support to help them cope with care transitions, to appropriately monitor their health, and to help them manage their interactions with members of the healthcare provider team. Unfortunately, there is currently a lack of psychosocial tools designed specifically to help survivors proactively manage their healthcare from the termination of treatment into extended survivorship. To fill this void, we draw on the social and behavioral science evidence base in social interaction and health communication to develop and test a highly innovative, self-management intervention: Extended Cancer Education for Longer-term Survivors (EXCELS). Based on health communication best practices, as well as on smart technology for ready access to patients, the EXCELS intervention will consist of (1) enhanced education and decision support materials delivered via mobile web and smart phone application and (2) health coaching engagement. The plan for intervention development involves three steps: first, during the formative phase, we will use qualitative methods (i.e., focus groups with survivors, depth interviews with primary care healthcare team members, user testing) to inform the design and iterative development of EXCELS. Second, we will pilot the intervention using a randomized controlled trial study design. Specifically, we will enroll 480 cancer survivors (breast, prostate, colorectal) who have completed active cancer treatment at least 2 years ago. The comprehensive EXCELS intervention consists of an ongoing 12 month intervention that entails (1) enhanced education and self-care support materials delivered via mobile web/smart phone application and (2) health coaching calls. A 2X2 factorial design will be used to test "proof of concept" or efficacy for the fully implemented EXCELS intervention compared with usual care so that the combined intervention - as well as each individual component - will be tested. The primary outcomes are use of preventive health services and tracking of cancer recurrence and late effects with patient coping as a secondary outcome. Outcomes will be assessed at baseline and at 6, 12, and 18 months by telephone interviews and chart audit by blinded research staff. Finally, a process evaluation of intervention implementation, as well as pilot data from this study, will be used to refine the intervention for testing in a larger implementation and dissemination research study.
美国有1370万癌症幸存者。到2050年,癌症幸存者的增长率预计将超过事件癌病例的增长率。大约70%的癌症幸存者的合并状况需要全面的医疗方法。然而,就需要的预防性护理和慢性疾病管理而言,癌症幸存者没有在适当水平上获得适当水平的建议后续护理。幸存者可能会受益于社会心理工具和支持,以帮助他们应对护理过渡,适当监控其健康,并帮助他们管理与医疗保健提供者团队成员的互动。不幸的是,目前缺乏专门设计的社会心理工具,以帮助幸存者从终止治疗中积极管理其医疗保健,从而扩展生存。为了填补这一空白,我们借鉴了社会互动和健康沟通中的社会和行为科学证据基础,以发展和测试高度创新的自我管理干预:长期幸存者的癌症教育扩展(Excels)。根据健康沟通的最佳实践以及智能技术,可以随时可以使用患者,excels干预措施将包括(1)通过移动网络和智能电话应用程序提供的增强教育和决策支持材料以及(2)健康教练参与。干预开发计划涉及三个步骤:首先,在形成阶段,我们将使用定性方法(即与幸存者的焦点小组,与初级保健医疗团队成员的深度访谈,用户测试)来告知Excels的设计和迭代开发。其次,我们将使用随机对照试验设计设计进行干预。具体而言,我们将招募480个癌症幸存者(乳房,前列腺, 结直肠癌)至少两年前已经完成了主动癌症治疗。综合性干预措施包括一个正在进行的12个月干预措施,该干预需要(1)通过移动网络/智能电话应用程序和(2)健康教练电话提供的增强教育和自我保健支持材料。与通常的护理相比,将使用2x2阶乘设计来测试完全实施的“概念验证”或功效,以符合干预措施,以便将测试合并的干预措施以及每个组件。主要结果是使用预防性保健服务以及跟踪癌症复发和患者应对作为次要结果的后期影响。结果将在基线和6、12和18个月的电话访谈和盲目研究人员进行图表审核中评估。最后,将对干预实施的过程评估以及本研究的试验数据,将用于完善在更大的实施和传播研究中进行测试的干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHAWNA V. HUDSON其他文献

SHAWNA V. HUDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHAWNA V. HUDSON', 18)}}的其他基金

Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance
使用量身定制的移动医疗干预措施来减少城市宫颈癌的差异,以提高阴道镜检查的出勤率
  • 批准号:
    10659894
  • 财政年份:
    2023
  • 资助金额:
    $ 62.67万
  • 项目类别:
Re-entry Supplement to Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者 (EXCELS) 扩展癌症教育的重返补充
  • 批准号:
    8843650
  • 财政年份:
    2013
  • 资助金额:
    $ 62.67万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9379052
  • 财政年份:
    2013
  • 资助金额:
    $ 62.67万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9326812
  • 财政年份:
    2013
  • 资助金额:
    $ 62.67万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8917755
  • 财政年份:
    2013
  • 资助金额:
    $ 62.67万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8641008
  • 财政年份:
    2013
  • 资助金额:
    $ 62.67万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8700941
  • 财政年份:
    2011
  • 资助金额:
    $ 62.67万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8133263
  • 财政年份:
    2011
  • 资助金额:
    $ 62.67万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8230599
  • 财政年份:
    2011
  • 资助金额:
    $ 62.67万
  • 项目类别:
Life After Cancer: Examining Survivor Transitions From Specialist to Primary Care
癌症后的生活:检查幸存者从专科护理到初级护理的转变
  • 批准号:
    8700972
  • 财政年份:
    2008
  • 资助金额:
    $ 62.67万
  • 项目类别:

相似国自然基金

面向掌纹识别的安全与隐私保护理论和方法研究
  • 批准号:
    62376211
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
微观市场均衡视角下中国长期护理保险试点的福利分析与政策评估
  • 批准号:
    72304093
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向康复护理机器人的人机信任度评估方法与任务影响机制研究
  • 批准号:
    62306195
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于生命质量的癌症患者心理行为与护理干预
  • 批准号:
    72381240026
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    国际(地区)合作与交流项目
天然水体中药品和个人护理品间接光降解产物预测模型的构建和应用
  • 批准号:
    42307496
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

RNA biomarkers for alcohol use disorder
酒精使用障碍的 RNA 生物标志物
  • 批准号:
    10808532
  • 财政年份:
    2023
  • 资助金额:
    $ 62.67万
  • 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
  • 批准号:
    10546293
  • 财政年份:
    2023
  • 资助金额:
    $ 62.67万
  • 项目类别:
Stepped Care, Peer-Delivered Intervention to Improve ART Adherence and SUD in Primary Care
阶梯式护理、同伴提供的干预措施可提高初级护理中的 ART 依从性和 SUD
  • 批准号:
    10675089
  • 财政年份:
    2022
  • 资助金额:
    $ 62.67万
  • 项目类别:
Newborn screening and treatment monitoring for patients with pyridoxine-dependent epilepsy
吡哆醇依赖性癫痫患者的新生儿筛查和治疗监测
  • 批准号:
    10372396
  • 财政年份:
    2022
  • 资助金额:
    $ 62.67万
  • 项目类别:
Treating Polysubstance Use in Methadone Maintenance: Application of Novel Digital Technology
治疗美沙酮维持中的多物质使用:新型数字技术的应用
  • 批准号:
    10588517
  • 财政年份:
    2022
  • 资助金额:
    $ 62.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了